Search Results - "Moriceau, G."

2591 Surgical resection of brain metastasis from renal cancer: Is it worth it? The experience of a French Cancer Center by Eberst, L, Flechon, A, Negrier, S, Neidhardt, E.M, Jouanneau, E, Moriceau, G, Boyle, H.J

Get full text

Therapeutic approach of primary bone tumours by bisphosphonates by Moriceau, G, Ory, B, Gobin, B, Verrecchia, F, Gouin, F, Blanchard, F, Redini, F, Heymann, D

“…Bone tumours can be dissociated in two main categories: i) primary bone tumours (benign or malignant) including mainly osteosarcoma and other sarcomas.ii)and…”
Get more information

Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment by Lamoureux, F., Moriceau, G., Picarda, G., Rousseau, J., Trichet, V., Rédini, F.

“…Tumor development in bone is often associated with fractures, bone loss and bone pain, and improvement is still needed in therapeutic approaches. Bone tumors…”
Get full text

Pharmacological blocking of the osteoclastic biocorrosion of surgical stainless steel in vitro by Lionetto, S., Little, A., Moriceau, G., Heymann, D., Decurtins, M., Plecko, M., Filgueira, L., Cadosch, D.

“…In vitro studies suggest that human osteoclasts (OC) are able to corrode surgical stainless steel 316L (SS). The aim of this study was to investigate whether…”
Get full text

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells by Ory, B., Moriceau, G., Trichet, V., Blanchard, F., Berreur, M., Rédini, F., Rogers, M., Heymann, D.

“…We recently demonstrated original anti‐tumor effects of zoledronic acid (Zol) on osteosarcoma cell lines independently of their p53 and Rb status. The present…”
Get full text

Carcinomatous meningitis: The radiation therapist's point of view by Espenel, S, Vallard, A, Langrand-Escure, J, Ben Mrad, M, Méry, B, Rivoirard, R, Moriceau, G, Guy, J-B, Trone, J-C, Moncharmont, C, Wang, G, Diao, P, Bernichon, É, Chanal, É, Fournel, P, Magné, N

“…Carcinomatous meningitis complicates 5 to 10% of cancers, essentially with breast cancers, lung cancers and melanomas. The incidence probably increased because…”
Get full text

Synergistic effect of apomine and lovastatin on osteosarcoma cell growth by Moriceau, G, Roelofs, A.J, Brion, R, Ebetino, H.F, Rogers, M, Heymann, D

Get full text

Synergistic inhibition of osteosarcoma cell growth by combination of RAD001 (everolimus) and zoledronic acid by Moriceau, G, Ory, B, Mitrofan, L, Brion, R, Charrier, C, Pilet, P, Shultz, L, Monkkonen, J, Rédini, F, Heymann, D

Get full text

Preventing healthcare-associated infections: Residents and attending physicians need better training in advanced isolation precautions by Moriceau, G., Gagneux-Brunon, A., Gagnaire, J., Mariat, C., Lucht, F., Berthelot, P., Botelho-Nevers, E.

“…Compliance with advanced isolation precautions (IPs) is crucial to reduce healthcare-associated infections. Our aim was to evaluate physician's knowledge and…”
Get full text

Oligometastatic breast cancer : therapeutic implications of a new paradigm by Méry, B, Moriceau, G, Vallard, A, Jacquin, J P, Magné, N

“…Oligometastatic breast cancer incidence is recently increasing thanks to screening and imaging improvements. Unlike patients with metastatic disease, a small…”
Get full text

General management of nonagenarian patients: a review of the literature by Rivoirard, Romain, Chargari, Cyrus, Trone, Jane-Chloé, Falk, Alexander Tuan, Guy, Jean-Baptiste, Eddekaoui, Houda, Lahmar, Rima, Pacaut, Cécile, Mery, Benoite, Assouline, Avi, Auberdiac, Pierre, Moriceau, Guillaume, Gonthier, Regis, Guillot, Aline, Merrouche, Yacine, Magné, Nicolas

“…The number of nonagenarian people in the world is steadily growing. This phenomenon will increase in future years: in 2050, world population prospects estimate…”
Get full text

First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma: data on safety and efficacy by Chargari, Cyrus, Pacaut, Cécile, Le Moulec, Sylvestre, Moriceau, Guillaume, Moussaid, Yassine, Rivoirard, Romain, Dulou, Renaud, Jacob, Julian, Guy, Jean-Baptiste, Bauduceau, Olivier, Ceccaldi, Bernard, Védrine, Lionel, Fournel, Pierre, Magné, Nicolas

“…The folate antimetabolite pemetrexed was approved for the treatment of patients with metastatic nonsquamous non-small-cell lung carcinoma. Its activity on…”
Get full text

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells by Ory, Benjamin, Moriceau, Gatien, Trichet, Valerie, Blanchard, Frederic, Berreur, Martine, Redini, Francoise, Rogers, Mike, Heymann, Dominique

Get full text

Méningite carcinomateuse : le point de vue de l’oncologue radiothérapeute by Espenel, S., Vallard, A., Langrand-Escure, J., Ben Mrad, M., Méry, B., Rivoirard, R., Moriceau, G., Guy, J.-B., Trone, J.-C., Moncharmont, C., Wang, G., Diao, P., Bernichon, É., Chanal, É., Fournel, P., Magné, N.

Get full text

Méningite carcinomateuse : le point de vue de l’oncologue radiothérapeute by Espenel, S., Vallard, A., Langrand-Escure, J., Ben Mrad, M., Méry, B., Rivoirard, R., Moriceau, G., Guy, J.-B., Trone, J.-C., Moncharmont, C., Wang, G., Diao, P., Bernichon, É., Chanal, É., Fournel, P., Magné, N.

“…La méningite carcinomateuse complique 5 à 10 % des cancers, le plus souvent des cancers du sein, des cancers broncho-pulmonaires ou des mélanomes. Son…”
Get full text

Méningite carcinomateuse : le point de vue de l’oncologue radiothérapeute by Espenel, S., Vallard, A., Langrand-Escure, J., Ben Mrad, M., Méry, B., Rivoirard, R., Moriceau, G., Guy, J.-B., Trone, J.-C., Moncharmont, C., Wang, G., Diao, P., Bernichon, É., Chanal, É., Fournel, P., Magné, N.

Get full text